Cited 0 time in
Unveiling the clinical and genetic impact of neuropsychiatric involvement in systemic lupus erythematosus
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cha, Soojin | - |
| dc.contributor.author | Ahn, Ga Young | - |
| dc.contributor.author | Kim, Kwangwoo | - |
| dc.contributor.author | Lee, Hye-Soon | - |
| dc.contributor.author | Bae, Sang-Cheol | - |
| dc.contributor.author | Bang, So-Young | - |
| dc.date.accessioned | 2025-11-11T01:30:24Z | - |
| dc.date.available | 2025-11-11T01:30:24Z | - |
| dc.date.issued | 2025-10 | - |
| dc.identifier.issn | 2056-5933 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/209079 | - |
| dc.description.abstract | Objectives Despite the clinical significance of neuropsychiatric systemic lupus erythematosus (NPSLE), which is a severe complication of SLE, clinical and genetic studies on NPSLE remain limited. This study aimed to identify the clinical features of NPSLE and explore genetic factors associated with NPSLE in a prospective lupus cohort. Methods The clinical features, disease activity and organ damage of 1205 Korean patients with SLE were assessed at least annually, and genome-wide genotyping with imputation was performed. The clinical and genetic associations of NPSLE, excluding minor events, and its specific subsets (seizure or psychosis) compared with those of non-NPSLE were analysed using genome-wide association studies (GWASs). The biological relevance of the identified loci was investigated through functional analyses. Results A total of 271 patients with NPSLE exhibited more clinically diverse manifestations (p=2.40×10−4), especially in patients with seizure (N=84, p=4.86×10−14) and psychosis (N=26, p=8.29×10−5), compared with 934 patients with non-NPSLE. Notably, NPSLE patients significantly had greater organ damage (total Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score: OR 1.49, p=3.28×10−17; non-NP SDI score: OR 1.22, p=7.61×10−5) than patients with non-NPSLE, adjusting for age, sex, hypertension, disease duration and antiphospholipid antibodies. GWAS revealed nine NPSLE-associated loci at a suggestive significance level (p<5×10⁻⁶). The nine nearest mapped genes were exclusively expressed in the brain (adjusted p=5.28×10−4), particularly in the basal ganglia, cortex and hippocampus (adjusted p<0.05). Conclusions Neuropsychiatric involvement in SLE increases clinical manifestations and extends organ damage beyond the nervous system, with NPSLE-related genetic variants highlighting their potential functional roles in various brain regions. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | EULAR | BMJ Publishing Group Ltd | - |
| dc.title | Unveiling the clinical and genetic impact of neuropsychiatric involvement in systemic lupus erythematosus | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1136/rmdopen-2025-006033 | - |
| dc.identifier.scopusid | 2-s2.0-105018219927 | - |
| dc.identifier.wosid | 001591366300001 | - |
| dc.identifier.bibliographicCitation | RMD Open, v.11, no.4, pp 1 - 9 | - |
| dc.citation.title | RMD Open | - |
| dc.citation.volume | 11 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 9 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.subject.keywordPlus | GENOME-WIDE ASSOCIATION | - |
| dc.subject.keywordPlus | GLUTAMATE-RECEPTOR | - |
| dc.subject.keywordPlus | CRITERIA | - |
| dc.subject.keywordPlus | MANIFESTATIONS | - |
| dc.subject.keywordPlus | CLASSIFICATION | - |
| dc.subject.keywordPlus | METAANALYSIS | - |
| dc.subject.keywordPlus | VALIDATION | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | ANTIBODIES | - |
| dc.subject.keywordPlus | CHINESE | - |
| dc.subject.keywordAuthor | Lupus Erythematosus | - |
| dc.subject.keywordAuthor | Risk Factors | - |
| dc.subject.keywordAuthor | Polymorphism | - |
| dc.subject.keywordAuthor | Systemic | - |
| dc.subject.keywordAuthor | Genetic | - |
| dc.identifier.url | https://rmdopen.bmj.com/content/11/4/e006033 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
